SCHEMBL43753

SCHEMBL43753

[CH2]CCC(C)(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5984121 0.82
SCHEMBL231308 0.81
SCHEMBL625211 0.79 TDP1 (0.32)
SCHEMBL20609970 0.78 TSHR (0.46)
SCHEMBL149818 0.78
SCHEMBL232097 0.78
SCHEMBL620976 0.78 TSHR (0.33)
SCHEMBL25386399 0.77 FFAR1 (0.36)
SCHEMBL10316599 0.77 FFAR1 (0.36)
SCHEMBL3891070 0.77 FFAR1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3911 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667631-B2 FGFR4 inhibitor, preparation method therefor, and applications thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-06-06 US claimed
CN-115224197-A Application of D-pi-A type passivation molecules taking benzotriazoles as donors in perovskite solar cell 大连理工大学 2022-10-21 CN claimed
EP-2360143-B1 SULFONE COMPOUNDS FOR USE AS SOLVENT FOR ELECTROCHEMICAL DEVICES SUMITOMO SEIKA CHEMICALS (JP) 2017-08-16 EP claimed
WO-2016037223-A1 DIRHODIUM COMPOUNDS AND METHODS OF USE GHANEM ASHRAF (AU) 2016-03-17 WO claimed
CN-102216264-B Sulfone compound SUMITOMO SEIKA CHEMICALS 2014-01-15 CN claimed
US-8466324-B2 Sulfone compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-06-18 US claimed
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
WO-2008084046-A1 PLASTICIZERS FOR POLYVINYL ACETALS AND POLYSULFIDES BASF SE (DE) 2008-07-17 WO claimed
WO-2006065842-A2 5,6,7,8-TETRAHYDROQUINOLINES AND RELATED COMPOUNDS AND USES THEREOF SYNTA PHARMACEUTICALS CORP. (US) 2006-06-22 WO claimed
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP claimed
US-20050203119-A1 Dihydropyridine compounds for treating or preventing metabolic disorders SYNTA PHARMACEUTICAL CORP. 2005-09-15 US claimed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO claimed
WO-2024148932-A1 EGFR C797S MUTATION INHIBITOR AND PHARMACEUTICAL USE THEREOF 上海和誉生物医药科技有限公司 2024-07-18 WO disclosed
CN-114845739-B Pharmaceutical conjugate of eribulin derivative, preparation method and application thereof in medicine 上海森辉医药有限公司 2024-07-16 CN disclosed
CN-113939516-B Methods and compositions for targeting protein degradation 珃诺生物医药科技(杭州)有限公司 2024-07-16 CN disclosed
CN-118324761-A USP inhibitor, preparation method and application thereof 北京华森英诺生物科技有限公司 2024-07-12 CN disclosed
US-4081478-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-03-28 US disclosed
US-4073808-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-02-14 US disclosed
US-4033989-A 9-Deoxy-PGF2 Analogs THE UPJOHN COMPANY (US) 1977-07-05 US disclosed
US-4016184-A PROSTAGLANDINS, BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1977-04-05 US disclosed